-
UPS Healthcare Continues Global Facility Expansion
contractpharma
June 16, 2020
Significant new facility space to support Coronavirus-related logistics in California with plans to expand up to 1.5M sq. ft.
-
Integrity Bio Announces Newly Validated Biotech Manufacturing Line
contractpharma
June 15, 2020
Integrity Bio has announced the validation of its second fill/finish manufacturing line. This plant expansion more than doubles the company’s manufacturing capacity to meet growing demand in the field.
-
Arranta Bio Expands Microbiome Capacity at CoE
contractpharma
May 29, 2020
Adds additional early-clinical GMP capacity for microbiome process development and early clinical supply at Gainesville, FL site.
-
Biocon Biologics receives EU GMP Certification for multiple Biosimilars manufacturing facilities in
expresspharma
May 20, 2020
These facilities are used for the manufacture of DS and DP for Biosimilars: Bevacizumab, Trastuzumab, Pegfilgrastim and secondary packaging of Insulin Glargine for EU markets.
-
Lincoln Pharmaceuticals receives EU GMP approval
expresspharma
May 20, 2020
The company looks to enter the EU markets very soon with its dermatology, gastro and pain management products and gradually expand product portfolio.
-
EU GMP Certification for Biocon Biologics Drug Substance Facilities in Bengaluru
expresspharma
May 14, 2020
These facilities were inspected by the regulatory agency between January 20 and 23, 2020.
-
Nanoform Awarded GMP Certification
contractpharma
May 07, 2020
To manufacture investigational drug developed using its CESS nanoparticle engineering platform for use in clinical trials.
-
CDSCO extends WHO-GMP/CoPP validity by six months
expresspharma
May 04, 2020
The validities of WHO GMP/CoPP expiring between March to August 2020 will be extended by six months from the date of expiry of the certificate as per WHO GMP certification guidelines.
-
WuXi Biologics Successfully Completes PFS Filling at its Robotic Aseptic Filling Facility
PharmaSources.com
April 29, 2020
First GMP facility in WuXi Biologics to use robotic aseptic filling line for biologics; Demonstrated diverse and flexible aseptic filling capability while maintaining high-quality and controlled filling accuracy as well as aseptic assurance.
-
WuXi Biologics (Suzhou) Successfully Passed First EMA GMP Inspection
Wuxi Biologics
April 14, 2020
WuXi Biologics, a global company with leading open-access biologics technology platform, announced that WuXi Biologics (Suzhou) Co., Ltd. has successfully passed its first GMP inspection by the European Medicines Agency (EMA).